Who is Arc Nouvel: Dr. Vivian Li on Strategy, Risk, and Value in Clinical Development
Across the drug development lifecycle, including pre-IND readiness, early clinical transitions, manufacturing evolution, and regulatory engagement, biotech and pharmaceutical companies turn to Arc Nouvel for specialized guidance. In oncology and beyond, the firm’s clients are often navigating early clinical decisions...
